Prognostic role of simplified Pulmonary Embolism Severity Index and the European Society of Cardiology Prognostic Model in short- and long-term risk stratification in pulmonary embolism

dc.authoridGunen, Hakan/0000-0001-6631-4457
dc.authoridHacievliyagil, Suleyman Savas/0000-0002-2572-1870
dc.authoridKilic, Talat/0000-0001-8125-9062
dc.authoridözer, ali/0000-0002-7144-4915
dc.authoridGulbas, Gazi/0000-0002-9435-8307
dc.authorwosidGunen, Hakan/HKV-9202-2023
dc.authorwosidHacievliyagil, Suleyman Savas/ABI-7307-2020
dc.authorwosidKilic, Talat/ABI-4457-2020
dc.authorwosidözer, ali/ABI-2209-2020
dc.authorwosidGulbas, Gazi/ABI-5182-2020
dc.contributor.authorKilic, Talat
dc.contributor.authorGunen, Hakan
dc.contributor.authorGulbas, Gazi
dc.contributor.authorHacievliyagil, Suleyman Savas
dc.contributor.authorOzer, Ali
dc.date.accessioned2024-08-04T21:00:55Z
dc.date.available2024-08-04T21:00:55Z
dc.date.issued2014
dc.departmentİnönü Üniversitesien_US
dc.description.abstractObjectives: Hemodynamic status, cardiac enzymes, and imaging-based risk stratification are frequently used to evaluate a pulmonary embolism (PE). This study investigated the prognostic role of a simplified Pulmonary Embolism Severity Index (sPESI) score and the European Society of Cardiology (ESC) model. Methods: The study included 50 patients from the emergency and pulmonology department of,one medical center between October 2005 and June 2006. The ability of the sPESI and ESC model to predict short-term (in-hospital) and long-term (6-month and 6-year) overall mortality was assessed, in addition to the accurancy of the sPESI and ESC model in predicting short-term adverse events, such as cardiopulmonary resuscitation, or major bleeding. Results: Of the 50 patients, the in-hospital and 6-year mortality rates were 14% and 46%, respectively. Fifteen (30%) of these experienced adverse events during hospitalization. Importantly, patients classified as low-risk according to the sPESI had no short-term adverse events as opposed to 4.8 % in the ESC low-risk group. They also had no in-hospital, 6-month, or 6-year mortality compared to 4.8%, %14.3, and %23.8, respectively, in the ESC low-risk group. Conclusions: The sPESI predicted short-term and long-term survival. The exclusion of short-term adverse events does not appear to require imaging and laboratory testing.en_US
dc.identifier.endpage1264en_US
dc.identifier.issn1682-024X
dc.identifier.issue6en_US
dc.identifier.pmid25674119en_US
dc.identifier.startpage1259en_US
dc.identifier.urihttps://hdl.handle.net/11616/103927
dc.identifier.volume30en_US
dc.identifier.wosWOS:000346112400017en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherProfessional Medical Publicationsen_US
dc.relation.ispartofPakistan Journal of Medical Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMortalityen_US
dc.subjectPulmonary embolismen_US
dc.subjectPrognostic modelen_US
dc.subjectRisk assessmenten_US
dc.titlePrognostic role of simplified Pulmonary Embolism Severity Index and the European Society of Cardiology Prognostic Model in short- and long-term risk stratification in pulmonary embolismen_US
dc.typeArticleen_US

Dosyalar